NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/10/2022
Voltar para busca
Dado oficial do USPTO
PANDAOMICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
11/10/2022
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
03/11/2020
Data de registro
11/10/2022
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/10/2022
Última transação
11/10/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
12/11/2020
Primeiro uso no comércio
26/01/2021
Código do desenho
4
Tipo de titular
77
Localização do titular
Central, HK
Examinador
COGAN, BRITTNEY
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Insilico Medicine IP Limited
Representantes
Louise Arnott MICHAEL BEST & FRIEDRICH LLP
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable and recorded computer software and computer programs using artificial intelligence for collectinganalyzinginterpreting and reporting data and information for drug design and development; data processing apparatus for the accumulationprocessing and storage of drug design and development data; none of the foregoing being computer security goods
Classe 42
Computer software design; Software as a service (SAAS) services featuring software for using artificial intelligence for collectinganalyzinginterpreting and reporting data and information in the field of drug design and development; software development in the framework of software publishing; platform as a service (PAAS) featuring computer software platforms for using artificial intelligence for collectinganalyzinginterpreting and reporting data and information in the field of drug design and development; development of computer platforms; computer system design; rental of computer software; creating and designing website based indexes of data and information for others using information technology; computer programming services; maintenance of computer software; research and development of new products for others; scientific and technological research relating to patent mapping; scientific research; installation of computer software; installationmaintenanceupdating of computer software; installation of software using artificial intelligence for automated machine learning in the field of drug design and development; customizing computer software; custom design of computer software; developing customized software in the field of drug design and development; all of the foregoing for use in for collectinganalyzinginterpreting and reporting data and information in the field of drug design and development; none of the foregoing being computer security services
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
11/10/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/09/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/09/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/09/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
31/08/2022
IUAF
USE AMENDMENT FILED
17/08/2022
EISU
TEAS STATEMENT OF USE RECEIVED
17/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14/07/2022
EX2G
SOU EXTENSION 2 GRANTED
12/07/2022
EXT2
SOU EXTENSION 2 FILED
12/07/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/01/2022
EX1G
SOU EXTENSION 1 GRANTED
10/01/2022
EXT1
SOU EXTENSION 1 FILED
10/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/09/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
29/09/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/09/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13/07/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/05/2021
PUBO
PUBLISHED FOR OPPOSITION
18/05/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/04/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/04/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/04/2021
GNRT
NON-FINAL ACTION E-MAILED
07/04/2021
CNRT
NON-FINAL ACTION WRITTEN
07/04/2021
DOCK
ASSIGNED TO EXAMINER
07/04/2021
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
04/03/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2021
NWAP
NEW APPLICATION ENTERED
06/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PANDAOMICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.